Fentanyl pain patches are recalled

Feb 18, 2008

The U.S. Food and Drug Administration announced the recall of Fentanyl transdermal system patches due to a potential safety hazard.

Actavis Inc. announced 14 lots of the patches sold nationwide might have a fold-over defect that could cause the patch to leak and expose patients or caregivers directly to the fentanyl gel. The FDA said Fentanyl is a potent opioid medication and exposure to the gel might lead to serious adverse events, including respiratory depression and possible overdose, which may be fatal.

Anyone who comes in contact with fentanyl gel should thoroughly rinse exposed skin with large amounts of water only; do not use soap, the company said.

Fentanyl transdermal patches are indicated for the management of persistent, moderate to severe chronic pain that requires continuous, around the clock opioid administration for an extended period of time and that cannot be managed by other means.

Complete recall information, including lot numbers, is available at
www.fda.gov/oc/po/firmrecalls/actavis02_08.html

Copyright 2008 by United Press International

Explore further: Pharmacists' group discourages providing execution drugs (Update)

Related Stories

Recommended for you

Japan's Takeda offers $2.2 bn to settle US drug lawsuits

6 hours ago

Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.